Open session of the standing technical committee of the EUFMD- 2004

Page 112

Discussion FMDV infection and clinical disease were widespread in the index village and all age groups were affected although the most severe disease, including lameness and the presence of interdigital lesions, was only evident in juvenile cattle. The onset of clinical FMD in Ozbek in September 2004 would appear to be associated with the recent purchase of young cattle from Erzurum market, most probably because of introduction of virus with these animals. However, there was also both epidemiological and serological evidence that an FMD outbreak had occurred in the village in the recent past, approximately 5 months before the present outbreak. Therefore it is also possible that the bought-in calves which were the most severely-affected group in the present outbreak may have developed disease because of being exposed to virus which was already present in the village in persistently-infected or subclinically-infected animals. For practical reasons neither of the rapid tests evaluated in this pilot study were actually applied “penside” but both were immediately used on return of the investigative team to the LDCC. Both tests were relatively easy to perform although a steady surface and pipetting were required. The test for detection of FMD viral antigen worked very well when it was used to test vesicular fluid and both specimens were strongly positive for both SP and NSP antigens. However, intact vesicles from which vesicular fluid could be obtained are infrequently observed in field cases of FMD. Furthermore, when “classical” vesicles are recognisably present, the clinical diagnosis is relatively certain and there may be little reason to perform a rapid test. The test performed poorly with OP fluid specimens in that many of the test-strips did not register a positive control line even where the specimen was diluted to reduce its viscosity. Although three specimens gave a very weak positive reaction (“trace” positives), these results had to be considered inconclusive given the absence of a control line on the testing device in each case. In addition it should be remembered that probangsampling is unlikely to be performed during an outbreak investigation and requires the readyavailability of probang devices and considerable experience on the part of the sampler. The usefulness of a rapid test for FMD antigen, which is only designed to test vesicular fluids and OP fluids and which in fact is only effective in testing the former, must be questioned. To be of use in field investigation it should be possible with a rapid testing method to use epithelial fragments from the edge of lesions as the clinical specimen under test; this would require that a suspension could be prepared from such specimens under field conditions that would be capable of diffusing through the membrane of an immunochromatographic test device. In addition the test devices would have to be sufficiently sensitive to detect the much smaller concentrations of FMD viral antigen that might be expected in such test materials derived from FMDV-infected animals. Compared with results obtained when the same sera were retested using a laboratory-based ELISA test-kit the rapid test devices for detection of NSP-antibody did not detect very many seropositive cattle. The rapid test was therefore much less sensitive for detection of NSP antibody than the laboratory-based ELISA. However these devices may still be of some use during initial epidemiological investigations at an infected premises or village. In such a situation it is important to estimate the time elapsed since introduction of infection for the purposes of tracing the most likely source of the infection and also to determine the risk of spread associated with different contacts. Establishing which was the first group of animals in a herd or village to become infected can be attempted by estimating the age of lesions in different epidemiological groups within the herd/village and thus identifying the oldest lesion present. This option is no longer available if lesions have healed. However, as a stronger serological response might be expected from animals with healed lesions (due to earlier exposure to the virus) a random-sample could be selected from each group of animals and their serum tested for the presence of NSP antibody. In addition, healing intra-oral lesions which are observed during an outbreak investigation may be caused by trauma or something else other than FMDV infection, as suspected in one of the groups examined during the present study. If the healed lesions were caused by FMD virus some indication of a serological response would be expected whilst no such response would be expected if the injury arose otherwise. Sera from such suspect animals could be collected and tested “penside” for this purpose. Conclusions • Rapid tests may be a useful tool during FMD outbreak investigation but they are NOT a substitute for careful clinical and epidemiological investigation • Available tests need further field evaluation and their use “penside” should be attempted. Acknowledgements The authors wish to thank staff in the Sap Institute, particularly Beyhan Sareyyupoglu, Oktay Tezal and Yusuf Demir. The authors also wish to thank Princeton Biomedical Corporation for providing test kits. 102


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.